Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Use of Second-line Immunotherapy in Control Arms of Randomized Clinical Trials in Kidney Cancer: A Systematic ReviewJAMA Netw Open 2021 Sep 01;4(9)e2124728, J Sharp, AR Khaki, V Prasad
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.